Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal-bolus therapy with insulin lispro protamine suspension versus insulin glargine in type 2 diabetes
2007-004864-29Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin lispro protamine suspension + insulin lispro with Insulin glargine + insulin lispro (2 arms). Primary endpoint: Glycemic control noninferiority. Started Jan 2008; status: completed.
02
Drugs
insulin lispro protamineinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-004864-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004864-29.